INTRODUCTION:
Healthcare-associated infections (HAI) are a major public health problem. The last European Point Prevalence Study reported a prevalence of 5.7% (4.5-7.4%) or 81,089 (64,624-105,895) patients with an HAI on any given day in European acute care hospitals. 1 Despite improvements in understanding and designing strategies for HAI prevention, this type of infection continues to lead to substantial morbidity, mortality and (direct and indirect) costs. One of the reasons for this is the substantial differences between the recommendations and daily practice. 2 Center for Disease Control and Prevention designed infection control precautions (ICP) to prevent transmission of infectious agents among patients and healthcare workers (HCW) in all settings where healthcare is delivered. ICP include Standard Precautions (applied to all patients, regardless of suspected or confirmed diagnosis) and Transmission-Based Precautions (divided in contact, droplet and airborne isolation). 3 Compliance to ICP is internationally suboptimal and this has significant implications for staff, patient and care environment safety. 4 Portuguese Infection and Antimicrobial Resistance Control
Program has published Standard Precautions, which all national healthcare institutions should follow. 5 More recently, the National Annual Report of Antimicrobial Resistance Surveillance recommended that the pre and post-graduation curricula of doctors, and other HCW, should include ICP. 6 The aim of our study was to assess the knowledge, source of information and perception of final year medical students and junior doctors about the prevention of transmission of infectious agents in healthcare settings.
METHODS:

Subjects and Sampling
This study was directed to the 5 th and 6 th year students and junior doctors (interns) from
Faculty of Medicine of University of Porto, a total of 889 individuals (290, 311 and 288, respectively). In Portugal, after 6 years of medical school, the student has to complete one year of internship before entering residency program. In this year, referred as the intern year, the junior doctor is not allowed to practice unsupervised medicine (only within his/her training internship program). Participants were invited, through email, to complete the questionnaire which was available online, between July and
October of 2015.
Questionnaire Design
A questionnaire was obtained and structured in four parts. The first one referred to participant's characteristics (8 questions) ; the second part addressed their knowledge in ICP (12 multiple choice questions, with only one correct answer) and was adapted from the knowledge domain of a questionnaire of a Swiss study of Sax et al. 7 ; the third part (three multiple choice questions) was dedicated to the participant's various sources of information and what they considered to be the main source (based on Amin et al. 8 ). In the last part, it was evaluated their perception about the contribution of the academic curriculum to their knowledge in this area, through five questions in Likert scale (based on Amin et al. 8 ) and their opinion about the main obstacles to compliance to ICP (four questions in Likert scale, based on Sax et al. 7 ).
Statistical Analysis
The Cronbach α test was used to assess the internal consistency of knowledge and perception questionnaire. In the knowledge score a correct answer was classified with one point, ranging between 0 and 12. In the perception score of curriculum adequacy, each of the five items ranged from 1 (strongly disagree) to 5 (strongly agree), ranging between 5 and 25. Two independent sample T-test or Analysis of Variances (ANOVA) was used to compare the means of the knowledge and perception scores. Significance level was fixed as 0.05.
RESULTS: Overall Population
A total of 225 questionnaires were returned, but two were eliminated due to missing data related to "academic year", leaving 223 questionnaires for analysis. Considering the target population, the response rate was 25.3%. The average age was 25.2 years (range, 21-48) and 70% were female. Regarding academic year, 38.1% were students from the 5 th year, 33.2% of the 6 th year and 28.7% were junior doctors ( Table 2) . A minority (6.3%) had been HCW before entering to medical school and 65.5% of the students admitted never having infection control training before.
Knowledge in ICP
The value of the Cronbach α test was 0.43. The mean of correct answers was 9.35 (SD±1.65) in a universe of 12 knowledge questions. The vast majority identified correctly the main purpose of hand hygiene (97.3%), the risk-guided application of a preventive strategy (97.3%) and the ubiquitous risk in body fluids (96.4%). On the other hand, only 61% answered correctly about glove use, 59.2% for mask indication and 29.6% knew the adequate procedures for contact isolation (Table 1) . Regarding the participants characteristics (Table 2) , there was a positive association between academic year and knowledge in ICP (9.10, 9.24, 9.79; P = .032), as well as previous training in ICP and knowledge (9.16 vs. 9.71; P = .016). Gender; being pre-med HCW and the type of source of information didn´t show significant statistical association with knowledge score.
Source of Information
We found a variety of opinions related to the most important source of information for infection control knowledge (Table 2) , in which 31.4% referred bedside practice, 28.3% bedside teaching, 25% the curriculum and 15.2% self-learning.
Perception of Curricular Adequacy
The value of the Cronbach α test was 0.48. The mean score of answers indicating curricular adequacy was 11.68 (SD±3.02). Half of the students disagreed that "current curriculum provides enough information on ICP" (50.2%) and more than half (53.7%)
disagreed that "training sessions about ICP are provided to medical students" (Table 3) .
They admitted the need to improve in this area (51.1% "agree" and 38% "strongly agree" the need to receive training in ICP). The ones that told us that their main source of information was "self-learning" are the ones that were more dissatisfied with the curriculum (P = .001) ( Table 2) . No association was found between the perception of curricular adequacy and knowledge in ICP (R = -0.015, P = .822).
When addressing the factors to explain the obstacles to compliance to ICP (Figure 1 ), our study revealed that more than half (53.4%) of the students agreed that "forgetfulness" and "lack of knowledge" were "very important" etiological factors.
"Lack of time" was also considered "very important" by 41.7% and "lack of means" was "important" to 52% of the participants. Figure 2 reflects the strategies proposed by the medical students to acquire competences in ICP, in which 26.9% think the best one is "bedside teaching", following 20.2% that prefer a combination of "curriculum and bedside teaching" and 15.7% who would prefer to learn through "bedside teaching and practice". On the other hand, only 1.3% considered self-learning as an isolated strategy to learn about ICP.
DISCUSSION:
This work, dealing with Portuguese medical students and junior doctors, allows to add some important aspects in the area of education of prevention and control of HAI, in terms of knowledge, source of information, perception and strategies to acquire infection control competences.
Knowledge in ICP
In the beginning of the 90´s Koenig and Chu reported worrisome results about the lack of knowledge of Universal Precautions in senior medical students at Washington School of Medicine. 9 Trying to deal with this problem, their colleagues described the positive results they achieved with a training program to medical students. 10 In the meantime, the Center for Disease Control and Prevention updated the guidelines in 1996 11 and, more recently, in 2007. 3 As Mann and Wood 12 referred, medical students are now having contact with patients earlier in their training and this can be a challenge, in terms of infection control knowledge, for these future doctors. In fact, these investigators reported that 58% of 3 rd year medical students from Birmingham University didn´t know the indications for alcohol-based handrub, and 35% were unaware of correct glove use. 12 In fact, in our study there were also some issues with poor results, as glove and mask use or the procedures for contact isolation. As already described in other studies, 13, 14 Legeay et al. 15 reported overall poor knowledge of medical students in the field of infection control, especially regarding personal protective equipment before providing care for an isolated patient. They found that the ones who were in final study years were associated with better scores. These results are according to what we found in our study: there was a positive association between academic year and knowledge in ICP. On the other hand, Jeffe et al. 16 found that students from preclinical years had better knowledge scores in ICP than clinical year students (P < .001). They attributed this difference to the more recent contact of preclinical students to the pathophysiology course but, they also concluded that, overall, student´s knowledge level was not impressive. 16 Other study 7 reported that knowledge in this area decreases, as the time since undergraduate training increases. They explained this fact due to the more recent introduction of this topic in basic training, so the new generation of professionals can more easily adopt newer concepts. In our study, a small part of the participants were already HCW before being medical students. area. In fact, in the present study we found a positive association between the medical students that admitted to have had previous training in ICP and their knowledge in this area.
Source of Information
In contrast with our results, Tavolacci et al. 18 finds that 86.7% of the 250 French healthcare students inquired, referred that the curriculum was the most important source of knowledge of ICP. On the other hand, the proportion that admitted to be "selflearning" is similar to our study. As alternative sources, they referred bedside practice and bedside teaching. La-Rotta et al. 19 found that 52.4% of the 208 Brazilian doctors studied also admitted that, the main source of knowledge of biosafety issues, was the undergraduate education (curriculum), following hospital in-training (30.4%) and selflearning (22.1%). In an Italian study 20 the HCW reported that their core source of information was training courses (71%), followed by scientific literature (48.2%).
However, most of them (85.3%) admitted the need to update what they already knew.
Perception of Curricular Adequacy
Amin et al. 8 reported that Saudi medical students perceived deficiencies in curriculum and training in ICP, admitting the need to improve in this area. In the present study, we can also conclude that the students who are more unhappy with the curriculum, are the ones that admit to have as main source of information "self-learning". In a Dutch study 21 , the majority of the medical students qualified their hygiene behavior as inadequate, which may explain why 61% considered it useful to receive more information on ICP. The authors concluded that this points to an educational deficit in the medical curriculum. On the other hand, Herbert et al. 22 found that 70% of 192
Austrian medical students considered their knowledge in hygiene standards as "excellent" or "good" and 74% referred having received a professional introduction to these guidelines but a vast majority (79%) still felt the need for more training in this area in their medical education. Interestingly, although two-thirds of a population of 273
Iranian nurses, midwives and students had previous infection control courses, 90.9% of them still admitted the need for more education in this area. 23 In a French study, 24 94%
of the participant medical students considered hygiene a priority when working in clinical areas, however 66.5% were dissatisfied by their hospital hygiene training.
Regarding the most relevant factors in explaining the obstacles to compliance to ICP, we agree with Sax et al. 7 findings: they reported that almost half (47.1%) of the students referred "lack of knowledge", followed by "lack of time" (41.7%) and "forgetfulness" (39.1%). Among a population of students and residents of Obstetrics, Helfgott et al. 25 described that the reasons HCW did not comply with ICP was mainly due to time constraints, "too much trouble" and perception of patient as not being infected.
Strategies to acquire infection control competences
As Cooke et al. 26 referred, students should have the opportunity to explore a variety of learning activities and methods that could allow them to achieve adequate competences.
In our study, we identified that the main strategies proposed by the medical students to acquire competences in ICP, were "bedside teaching" and a combination of "curriculum and bedside teaching". students who were observers in the hand hygiene campaign and concluded they believed to have gained more knowledge regarding hand hygiene compliance attitudes and crosstransmission epidemiology. In an Irish study, 34 an online infection control training course for medical students was developed and evaluated, with a statistically significant improvement in the knowledge level among the 517 students studied. In other study, 35 Portuguese medical students were inquired about their intention to comply with hand Page 13 hygiene. The authors found that the 1 st year students perceived professors as the most significant role model, while the 6 th year students focused on colleagues, as relevant social referents to model their compliance behavior. They concluded about the relevance of role models and mentors, as key factors in teaching hand hygiene to medical students. This idea was supported by Kaur et al. 36 that referred that sustainability of the practice of hand hygiene is likely to need role models and cultural change in infection control area. In fact, Frenk et al. 37 defended that, among other factors, coaching, instruction and role models are important for the development of major attributes of professional behavior, identity and values. In a detailed document, the "Commission on Education of Health Professionals for the 21 st Century" believes that the future will be shaped by adaptation of competencies to specific contexts, having as reference the global flows of information and knowledge. 37 Our study has some limitations, such as, the population studied is not representative of all Portuguese medical students (we studied a sample of one of the eight Portuguese medical schools, which have different curricula between them). Other limitation is that knowledge does not necessarily translate into attitude and practice. However, Askarian et al. 38 found a statistically significant positive correlation between knowledge vs.
attitude; knowledge vs. practice and practice vs. attitude in a group of 468 medical students towards ICP.
We can conclude that our study revealed reasonable knowledge in basic concepts of ICP. However, this sample of Portuguese medical students and junior doctors perceived deficiencies in curriculum and training received in this area, admitting the need to improve it. We found a positive association between academic year and knowledge, as well as, previous training in ICP and knowledge. Interestingly, only 25% of the students identified, as the main source of information for infection control knowledge, the Page 14 curriculum and, when asked about the obstacles to compliance to ICP, more than half considered "forgetfulness" and "lack of knowledge" very important etiological factors.
Finally, the strategies proposed by medical students to acquire competences in ICP,
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